Varrone A - Search Results

1

Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.

Farkas S, Nagy K, Jia Z, Hortobágyi T, Varrone A, Halldin C, Csiba L, Gulyás B. Farkas S, et al. Among authors: varrone a. Brain Res. 2012 May 9;1453:56-63. doi: 10.1016/j.brainres.2012.03.014. Epub 2012 Mar 14. Brain Res. 2012. PMID: 22480734

2

Extrastriatal dopamine D(2) receptor binding in Huntington's disease.

Esmaeilzadeh M, Farde L, Karlsson P, Varrone A, Halldin C, Waters S, Tedroff J. Esmaeilzadeh M, et al. Among authors: varrone a. Hum Brain Mapp. 2011 Oct;32(10):1626-36. doi: 10.1002/hbm.21134. Epub 2010 Sep 30. Hum Brain Mapp. 2011. PMID: 20886576 Free PMC article.

3

In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [¹⁸F]MNI-659.

Svedberg MM, Varnäs K, Varrone A, Mitsios N, Mulder J, Gulyás B, Beaumont V, Munoz-Sanjuan I, Zaleska MM, Schmidt CJ, Halldin C, Mrzljak L. Svedberg MM, et al. Among authors: varrone a. Brain Res. 2019 May 15;1711:140-145. doi: 10.1016/j.brainres.2019.01.021. Epub 2019 Jan 18. Brain Res. 2019. PMID: 30664847

4

Molecular imaging of the dopamine transporter.

Varrone A, Halldin C. Varrone A, et al. J Nucl Med. 2010 Sep;51(9):1331-4. doi: 10.2967/jnumed.109.065656. Epub 2010 Aug 18. J Nucl Med. 2010. PMID: 20720060 Free article. Review.

5

Brain uptake and distribution of the dopamine D3 /D2 receptor partial agonist [11 C]cariprazine: an in vivo positron emission tomography study in nonhuman primates.

Tóth M, Varrone A, Steiger C, Laszlovszky I, Horváth A, Kiss B, Gyertyán I, Adham N, Halldin C, Gulyás B. Tóth M, et al. Among authors: varrone a. Synapse. 2013 May;67(5):258-64. doi: 10.1002/syn.21631. Epub 2013 Feb 8. Synapse. 2013. PMID: 23238770

6

PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.

Cervenka S, Varrone A, Fransén E, Halldin C, Farde L. Cervenka S, et al. Among authors: varrone a. Synapse. 2010 Jun;64(6):478-85. doi: 10.1002/syn.20765. Synapse. 2010. PMID: 20175222

7

Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.

Fazio P, Svenningsson P, Forsberg A, Jönsson EG, Amini N, Nakao R, Nag S, Halldin C, Farde L, Varrone A. Fazio P, et al. Among authors: varrone a. J Nucl Med. 2015 May;56(5):714-20. doi: 10.2967/jnumed.114.152421. Epub 2015 Mar 19. J Nucl Med. 2015. PMID: 25791993 Free article.

8

Nigrostriatal dopamine transporter availability in early Parkinson's disease.

Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A. Fazio P, et al. Among authors: varrone a. Mov Disord. 2018 Apr;33(4):592-599. doi: 10.1002/mds.27316. Epub 2018 Feb 13. Mov Disord. 2018. PMID: 29436751 Clinical Trial.

9

Reliability of dopamine transporter PET measurements with [¹⁸F]FE-PE2I in patients with Parkinson's disease.

Kerstens VS, Fazio P, Sundgren M, Matheson GJ, Franzén E, Halldin C, Cervenka S, Svenningsson P, Varrone A. Kerstens VS, et al. Among authors: varrone a. EJNMMI Res. 2020 Aug 14;10(1):95. doi: 10.1186/s13550-020-00676-4. EJNMMI Res. 2020. PMID: 32797307 Free PMC article.

10

New developments of dopaminergic imaging in Parkinson's disease.

Varrone A, Halldin C. Varrone A, et al. Q J Nucl Med Mol Imaging. 2012 Feb;56(1):68-82. Q J Nucl Med Mol Imaging. 2012. PMID: 22460161 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters